The international group of experts, including Professor John Bridgewater (UCL Cancer Institute), is calling for rapid ...

Real-world comparative outcomes of FOLFOX vs FOLFIRI as second-line therapy in metastatic biliary tract cancer. In-hospital outcomes by initial biliary drainage strategy for malignant biliary ...

Initial biliary drainage strategy and in-hospital outcomes in malignant biliary obstruction: A national analysis. This is an ASCO Meeting Abstract from the 2026 ASCO Gastrointestinal Cancers Symposium ...

Zanidatamab, a bispecific HER2-targeted antibody, delivered clinically meaningful and durable responses for patients with HER2-positive biliary tract cancer (BTC), according to final results from the ...

Biliary tract cancers (BTCs) are notably aggressive and present significant treatment challenges within the realm of gastrointestinal malignancies. A primary impediment to enhancing patient outcomes ...

1 Division of Biliary Tract Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China 2 Department of Medical Ultrasound, West China Hospital, Sichuan ...

ABSTRACT: Stent occlusion is a well-known complication in patients needing decompression of the biliary tract, and it requires active intervention to prevent progression to cholangitis and further ...

ABSTRACT: Stent occlusion is a well-known complication in patients needing decompression of the biliary tract, and it requires active intervention to prevent progression to cholangitis and further ...

Zymeworks Inc. announced that their bispecific antibody, zanidatamab, has received conditional approval from China's National Medical Products Administration (NMPA) for treating previously treated, ...

STAT3-hyper IgE syndrome (STAT3-HIES) is a primary immunodeficiency disorder caused by dominant-negative mutations in STAT3, leading to defects in Th17 cell differentiation, immune regulation, and ...

Compass Therapeutics' tovecimig shows promise in biliary tract cancer with a 17.1% response rate, but further survival data is crucial for potential approval. CMPX's cash runway extends into early ...